Breaking News Instant updates and real-time market news.

CERU

Cerulean

$0.68

-0.0168 (-2.41%)

, NVS

Novartis

$76.31

0.73 (0.97%)

08:08
10/19/16
10/19
08:08
10/19/16
08:08

Cerulean announces strategic collaboration with Novartis

Cerulean Pharma (CERU) announced that the company has entered into a strategic collaboration with Novartis (NVS) to develop NDC product candidates combining Cerulean's proprietary Dynamic Tumor Targeting technology with Novartis' proprietary compounds directed at up to five targets. Cerulean will create NDC candidates, and Novartis is responsible for further development and commercialization of NDC products resulting from the collaboration. Under terms of the agreement, Cerulean will receive an upfront payment of $5M plus funding for five full-time equivalents. Cerulean is also eligible to receive preclinical, clinical, regulatory, and sales milestones for each target. In addition, following regulatory approval of NDC products, Cerulean can earn single-digit to low double-digit tiered royalties on net sales for each NDC product.

CERU

Cerulean

$0.68

-0.0168 (-2.41%)

NVS

Novartis

$76.31

0.73 (0.97%)

  • 11

    Nov

CERU Cerulean
$0.68

-0.0168 (-2.41%)

08/18/16
JMPS
08/18/16
DOWNGRADE
JMPS
Market Perform
Cerulean downgraded to Market Perform from Outperform at JMP Securities
JMP Securities analyst Michael King downgraded Cerulean after the company announced negative top-line results from a study of its CRLX101 drug in patients with advanced renal cell carcinoma. Noting that the study indicated that there was no difference between the results of patients taking CRLX101 and those taking the standard treatment, King says that the stock is fairly valued at current levels.
08/18/16
ROTH
08/18/16
NO CHANGE
Target $2.5
ROTH
Buy
Roth Capital trims Cerulean price target, but remains a buyer
Roth Capital analyst Joseph Pantginis lowered his price target for Cerulean to $2.50 from $9 after the company's Phase 2 clinical trial of CRLX101 for advanced renal cell carcinoma, or RCC, demonstrated no statistically significant difference. Nonetheless, with a platform technology providing long-term pipeline fill and improvements in tumor targeting, Pantginis believes Cerulean remains an attractive opportunity despite the failure in late-stage RCC. He reiterates a Buy rating on the shares.
08/18/16
08/18/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Sell from Hold at Evercore ISI with analyst Ken Sena saying he sees "more risk than reward" ahead of Snapchat's anticipated monetization ramp this fall. 2. Ambev (ABEV) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Jeronimo De Guzman saying valuation is full and sees difficult near-term trends ahead given lower disposable income, volume weakness, and lower realized pricing. 3. Icahn Enterprises (IEP) downgraded to Sell from Neutral at UBS saying the company's net asset value, despite declining 49% since second quarter of 2015, seems to include optimistic valuations. 4. Cerulean (CERU) downgraded to Neutral from Buy at Janney Capital, to Market Perform from Outperform at Leerink, and to Market Perform from Outperform at JMP Securities. 5. Magellan Midstream (MMP) downgraded to Underweight at Morgan Stanley with analysts led by Tom Abrams citing a relatively high valuation as the number of lower multiple investment choices has increased. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/18/16
WEDB
08/18/16
DOWNGRADE
WEDB
Neutral
Cerulean downgraded to Neutral from Outperform at Wedbush
NVS Novartis
$76.31

0.73 (0.97%)

08/31/16
PIPR
08/31/16
NO CHANGE
PIPR
Piper's Schimmer unsure of impact from Novartis CAR-T shakeup
Piper Jaffray analyst Joshua Schimmer said he's struggling with the implications of the news that Novartis (NVS) is reportedly eliminating its Cell and Gene Therapy unit as a stand-alone entity, which is primarily focused on development of CAR-T and adoptive immunotherapies. On the one hand, removing a leading competitor is a positive for the rest of the field, Schimmer tells investors in a research note. On the other hand, the move by Novartis could signal "significant challenges" in the field, the analyst adds. Schimmer continues to prefer companies "with unique and differentiated approaches," namely Bellicum Pharmaceuticals (BLCM), Cellectis (CLLS), Lion Biotechnologies (LBIO), Amgen (AMGN), Celgene (CELG) and bluebird bio (BLUE). Juno Therapeutics (JUNO) and Kite Pharma (KITE) are down 6% and 5%, respectively, in midday trading.
09/02/16
LEER
09/02/16
NO CHANGE
LEER
Outperform
Teva third Copaxone patent invalidated as expected, says Leerink
Leerink analyst Jason Gerberry says Teva (TEVA) suffered a largely expected loss in its Copaxone 40mg patent battle, with the Patent Trial and Appeal Board, or PTAB, ruling a third patent invalid. The analyst believes the company will likely appeal the loss, along with PTAB rulings rendered last week that other Copaxone patents were invalid. Gerberry sees the bull case scenario of Teva securing patent exclusivity of the Copaxone 40mg as unlikely and says a settlement with Momenta (MNTA) and Novartis (NVS) is the most logical course of action to mitigate 2017-2018E EPS risk. He reiterates an Outperform rating on Teva's shares.
09/20/16
CHDN
09/20/16
INITIATION
Target $95
CHDN
Buy
Novartis initiated with a Buy at Chardan
Chardan initiated Novartis with a Buy and a $95 price target.
10/13/16
JEFF
10/13/16
DOWNGRADE
Target $36
JEFF
Hold
Pfizer downgraded to Hold from Buy at Jefferies
Jefferies analyst Jeffrey Holford downgraded Pfizer (PFE) to Hold citing a lack of positive catalysts. The analyst says the drivers for his upgrade to Buy have either played out or have not materialized, namely an inversion or GEP unit separation. To reflect the infusion business disposal and weaker Ibrance trends, Holford cut his mid-term earnings estimates for Pfizer by up to 7% and cut his price target for the shares to $36 from $39. The stock closed yesterday down 6c to $33.07. The analyst also sees increased risk of a major acquisition occurring over the next 12 months. In the global pharma space, Holford lists AbbVie (ABBV), Eli Lilly (LLY), Novartis (NVS) and AstraZeneca (AZN) as his top picks.

TODAY'S FREE FLY STORIES

DOW

Dow Chemical

$63.09

-0.48 (-0.76%)

, DD

DuPont

$80.69

-0.47 (-0.58%)

16:59
06/27/17
06/27
16:59
06/27/17
16:59
Hot Stocks
Canada Competition Bureau reaches agreement with DuPont, Dow Chemical on merger »

Canada's Competition…

DOW

Dow Chemical

$63.09

-0.48 (-0.76%)

DD

DuPont

$80.69

-0.47 (-0.58%)

FMC

FMC Corporation

$74.01

-0.76 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

16:47
06/27/17
06/27
16:47
06/27/17
16:47
Hot Stocks
Global Medical REIT provides update on acquisition of cardiac clinic in Lubbok »

Global Medical REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:46
06/27/17
06/27
16:46
06/27/17
16:46
Hot Stocks
Ryerson comments on Q2 market conditions, demand environment »

In a press release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:43
06/27/17
06/27
16:43
06/27/17
16:43
Earnings
Ryerson sees Q2 net income $0M-$2M »

EPS consensus 35c. Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
06/27/17
06/27
16:38
06/27/17
16:38
General news
API crude inventories for week of June 23 »

API reports that crude…

SSTK

Shutterstock

$43.81

-0.94 (-2.10%)

16:37
06/27/17
06/27
16:37
06/27/17
16:37
Hot Stocks
Shutterstock to acquire Flashstock for approximately $50M cash »

Shutterstock announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$77.77

0.26 (0.34%)

16:36
06/27/17
06/27
16:36
06/27/17
16:36
Hot Stocks
Aflac recommends shareholders to reject mini-tender offer by TRC Capital »

Aflac announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AL

Air Lease

$36.97

0.13 (0.35%)

, BA

Boeing

$198.89

-1.09 (-0.55%)

16:34
06/27/17
06/27
16:34
06/27/17
16:34
Hot Stocks
Air Lease delivers Boeing 737-800 to Travel Service »

Air Lease Corporation…

AL

Air Lease

$36.97

0.13 (0.35%)

BA

Boeing

$198.89

-1.09 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CEMI

Chembio Diagnostics

16:33
06/27/17
06/27
16:33
06/27/17
16:33
Syndicate
Chembio establishes "at-the-market" program »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

OC

Owens Corning

$66.05

-0.65 (-0.97%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Owens Corning completes acquisition of Pittsburgh Corning for $560M »

Owens Corning announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLLS

Cellectis

$24.34

-0.69 (-2.76%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Cellectis announces first in human administration in AML study »

Cellectis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NSAT

Norsat

$11.50

0.1 (0.88%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Norsat receives court approval for arrangement with Hytera Communications »

Norsat International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEET

Meet Group

$4.85

0.01 (0.21%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Meet Group reaches agreement with Harvest Capital »

The Meet Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/27/17
06/27
16:30
06/27/17
16:30
Options
Preliminary option volume of 15.8M today »

Preliminary option volume…

16:25
06/27/17
06/27
16:25
06/27/17
16:25
Conference/Events
CFA Society of North Carolina to hold a panel discussion »

The CFA Society of North…

CVS

CVS Health

$80.49

0.37 (0.46%)

16:20
06/27/17
06/27
16:20
06/27/17
16:20
Initiation
CVS Health initiated  »

CVS Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
Initiation
Walgreens Boots Alliance initiated  »

Walgreens Boots Alliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

S

Sprint

$8.18

0.17 (2.12%)

, TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
General news
On The Fly: Top stock stories for Tuesday »

Stocks moved in a very…

S

Sprint

$8.18

0.17 (2.12%)

TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

CMCSA

Comcast

$39.25

-0.34 (-0.86%)

CHTR

Charter

$329.87

-2.78 (-0.84%)

VZ

Verizon

$44.84

-0.91 (-1.99%)

T

AT&T

$37.70

-0.45 (-1.18%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

MRK

Merck

$65.54

-0.38 (-0.58%)

MDLZ

Mondelez

$43.97

-0.93 (-2.07%)

WPPGY

WPP PLC

$104.96

-0.97 (-0.92%)

FDX

FedEx

$214.39

-0.97 (-0.45%)

CBI

CB&I

$20.02

5.62 (39.03%)

DRI

Darden

$92.69

2.61 (2.90%)

WDC

Western Digital

$91.85

-0.81 (-0.87%)

STX

Seagate

$39.51

-2.88 (-6.79%)

RARX

RA Pharmaceuticals

$17.69

-4.49 (-20.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 07

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 27

    Jul

  • 27

    Jul

  • 03

    Aug

  • 21

    Sep

  • 22

    Sep

CEMI

Chembio Diagnostics

16:18
06/27/17
06/27
16:18
06/27/17
16:18
Syndicate
Breaking Syndicate news story on Chembio Diagnostics »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

$NSD

NASDAQ Market Internals

16:17
06/27/17
06/27
16:17
06/27/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$23.32

-0.61 (-2.55%)

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Initiation
Square initiated  »

Square assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

$NYE

NYSE Market Internals

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$52.73

-1.01 (-1.88%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
PayPal initiated  »

PayPal assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

CFI

Culp

$32.25

-0.25 (-0.77%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Hot Stocks
Culp changes NYSE ticker symbol to 'CULP' »

Culp, Inc. announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAWK

Blackhawk

$41.90

-1.1 (-2.56%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
Blackhawk initiated  »

Blackhawk initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.